Target Name: MIR25
NCBI ID: G407014
Review Report on MIR25 Target / Biomarker Content of Review Report on MIR25 Target / Biomarker
MIR25
Other Name(s): hsa-miR-25-5p | hsa-miR-25-3p | hsa-mir-25 | microRNA 25 | MIRN25 | miR-25 | MicroRNA 25

Discovery and Research of MIR25: A Potential Drug Target and Biomarker for Various Diseases

MIR25 (hsa-miR-25-5p), a microRNA (miRNA), is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. MIR25 is a highly conserved miRNA that is expressed in various tissues and has been shown to play a role in various biological processes, including cell growth, apoptosis, and inflammation.

MIR25 is a part of the hsa-miR family, which consists of 21 non-coding RNAs that share a conserved antiparallel open reading frame structure. The hsa-miR25 gene is located at human chromosome 1p36.1, and its coding region consists of 1,092 nucleotides. The 3' end of MIR25 consists of a sequence composed of conserved amino acid residues, while the 5' end consists of an enhancer sequence bound by the AUG transcription factor.

Expression of MIR25 in various cancers

The expression status of MIR25 in various cancers indicates that it may have an important impact on tumor occurrence and development. Many studies have shown that the expression level of MIR25 is negatively correlated with cancer prognosis and treatment response. For example, in a study of colon cancer patients, expression levels of MIR25 were significantly decreased, while increased expression levels were associated with reduced patient survival.

Research on MIR25 as a drug target

The potential of MIR25 as a drug target has received widespread attention. Because MIR25 is expressed in a variety of cancers, it may become a promising drug target. Many studies are exploring how MIR25 interacts with tumor cells and how to treat tumors by interfering with MIR25's biological pathways.

Among them, some studies have explored the interaction between MIR25 and immune cells. In a study, scientists found that MIR25 can inhibit the killing effect of immune cells on tumor cells, thereby helping tumor cells evade immune surveillance. In addition, some studies have also found that MIR25 can regulate the role of immune cells in inhibiting tumor growth, which is of great significance in tumor treatment.

Biological functions of MIR25

MIR25 plays an important role in a variety of biological processes. Studies have shown that MIR25 can participate in a variety of biological processes, including cell cycle, apoptosis, cell proliferation and cell inflammation. MIR25 plays a key role in these biological processes, including regulating cell cycle, controlling apoptosis, promoting cell proliferation and regulating cell inflammation.

In addition, MIR25 can also participate in a variety of important biological pathways, such as cell proliferation and apoptosis pathways, cell cycle regulation pathways, and immune pathways. MIR25 can play an important role in these pathways, thereby having an important impact on life activities.

Clinical applications of MIR25

The application of MIR25 in tumor treatment has also received widespread attention. Many studies are exploring how MIR25 can treat tumors by interfering with MIR25's biological pathways. Some studies have found that MIR25 can be used as a drug target to treat tumors, and that various tumors can be treated by interfering with the biological pathways of MIR25.

For example, some studies have found that MIR25 can be used as a drug target to treat lung cancer. In one study, scientists found that MIR25 can inhibit the growth and spread of lung cancer cells, thereby helping lung cancer patients achieve better treatment results. In addition, some studies have also found that MIR25 can be used as a drug target to treat breast cancer, thereby inhibiting the growth and spread of breast cancer cells.

Biological value of MIR25

As an important non-coding RNA molecule, MIR25 plays an important role in a variety of biological processes. Many studies have shown that MIR25 can participate in a variety of important biological processes, including cell cycle, apoptosis, cell proliferation and cell inflammation. MIR25 plays a key role in these biological processes, including regulating cell cycle, controlling apoptosis, promoting cell proliferation and regulating cell inflammation.

In addition, MIR25 can also participate in a variety of important biological pathways, such as cell proliferation and apoptosis pathways, cell cycle regulation pathways, and immune pathways. MIR25 can play an important role in these pathways, thereby having an important impact on life activities.

Discovery and research of MIR25

MIR25, as a non-coding RNA molecule, was first discovered by researchers in 19

Protein Name: MicroRNA 25

The "MIR25 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR25 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR2681 | MIR2682 | MIR26A1 | MIR26A2 | MIR26B | MIR27A | MIR27B | MIR28 | MIR2861 | MIR2909 | MIR296 | MIR297 | MIR298 | MIR299 | MIR29A | MIR29B1 | MIR29B2 | MIR29B2CHG | MIR29C | MIR300 | MIR301A | MIR301B | MIR302A | MIR302B | MIR302C | MIR302D | MIR302E | MIR302F | MIR3059 | MIR3064 | MIR3065 | MIR3074 | MIR3085 | MIR30A | MIR30B | MIR30C1 | MIR30C2 | MIR30D | MIR30E | MIR31 | MIR3115 | MIR3116-1 | MIR3116-2 | MIR3117 | MIR3118-1 | MIR3118-2 | MIR3118-3 | MIR3118-4 | MIR3118-5 | MIR3118-6 | MIR3119-1 | MIR3119-2 | MIR3120 | MIR3121 | MIR3122 | MIR3123 | MIR3124 | MIR3125 | MIR3126 | MIR3127 | MIR3128 | MIR3129 | MIR3130-1 | MIR3130-2 | MIR3131 | MIR3132 | MIR3133 | MIR3134 | MIR3135A | MIR3135B | MIR3136 | MIR3137 | MIR3138 | MIR3139 | MIR3140 | MIR3141 | MIR3142 | MIR3142HG | MIR3143 | MIR3144 | MIR3145 | MIR3146 | MIR3147 | MIR3147HG | MIR3148 | MIR3149 | MIR3150A | MIR3150B | MIR3151 | MIR3152 | MIR3153 | MIR3154 | MIR3155A | MIR3155B | MIR3156-1 | MIR3156-2 | MIR3156-3 | MIR3157 | MIR3158-1 | MIR3158-2